Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
Condition(s):Cancer; Advanced Cancer; Advanced Solid Tumor; Mental Health Issue; Behavior DisordersLast Updated:April 19, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Cancer; Advanced Cancer; Advanced Solid Tumor; Mental Health Issue; Behavior DisordersLast Updated:April 19, 2023Recruiting
Condition(s):Myocardial Infarction; Cerebrovascular Accident; Death, Sudden, CardiacLast Updated:November 9, 2016Withdrawn
Condition(s):Adverse Drug Events; Adverse Drug Reactions; Drug Interaction Potentiation; Drug Metabolism, Poor, CYP2D6-RELATED; Drug Metabolism, Poor, CYP2C19-RELATED; Cytochrome P450 Enzyme Deficiency; Cytochrome P450 CYP2D6 Enzyme Deficiency; Cytochrome P450 CYP2C9 Enzyme Deficiency; Cytochrome P450 CYP2C19 Enzyme Deficiency; Cytochrome P450 CYP3A Enzyme Deficiency; Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant; Poor Metabolizer Due to Cytochrome P450 CYP2C19 Variant; Poor Metabolizer Due to Cytochrome P450 CYP2D6 VariantLast Updated:March 1, 2017Completed
Condition(s):HIV; TuberculosisLast Updated:October 17, 2012Unknown status
Condition(s):Cardiovascular Diseases; Heart Diseases; Myocardial Infarction; Hypertension; Cerebrovascular AccidentLast Updated:May 7, 2018Completed
Condition(s):Pharmacogenetic Testing; Elderly; Opioid Use; Pain; Pain, Acute; Pain, ChronicLast Updated:September 2, 2022Enrolling by invitation
Condition(s):Pharmacogenetics; Drug-Related Side Effects and Adverse Reactions; Cardiovascular DrugsLast Updated:April 1, 2022Recruiting
Condition(s):Adverse Drug Events; Adverse Drug Reactions; Drug Interaction Potentiation; Drug Metabolism, Poor, CYP2D6-RELATED; Drug Metabolism, Poor, CYP2C19-RELATED; Cytochrome P450 Enzyme Deficiency; Cytochrome P450 CYP2D6 Enzyme Deficiency; Cytochrome P450 CYP2C9 Enzyme Deficiency; Cytochrome P450 CYP2C19 Enzyme Deficiency; Cytochrome P450 CYP3A Enzyme Deficiency; Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant; Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant; Poor Metabolizer Due to Cytochrome P450 CYP2D6 VariantLast Updated:September 20, 2019Completed
Condition(s):Tuberculosis; HIVLast Updated:October 12, 2012Unknown status
Condition(s):Cytochrome P450 CYP2D6 Enzyme Deficiency; Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant; Ultrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant; Extensive Metabolizer Due to Cytochrome P450 CYP2D6 Variant; Cytochrome P450 CYP2C9 Enzyme Deficiency; Cytochrome P450 CYP2C19 Enzyme Deficiency; Drug Metabolism, Poor, CYP2D6-RELATED; Drug Metabolism, Poor, CYP2C19-RELATED; CYP2D6 PolymorphismLast Updated:February 23, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.